Get your free ETF data sample from our comprehensive offerings. Start your free trial→

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

Start Comparing ETFs Now!

›ETF Issuers›Amundi›LYMFE

LYMFE

Amundi Core MSCI EMU UCITS ETF

Dist

EUR

Passive ETF Equity

The LYMFE Exchange Traded Fund (ETF) is provided by Amundi. It is built to track an index: MSCI EMU Index. The LYMFE ETF provides physical exposure, so by buying it you actually own parts of all the 230 underlying holdings. This share class generates a stream of income by distributing dividends.

€85.97

+€0.39 (+0.46%) 2 days ago

7:00 AM 08/11/26 Open

1D price range

€85.97€86.11

52W price range

€69.94€85.87

YTD Perf.

+15.64%

YTD Flows

Annualized volatility

Fund AuM

€1.42B

Share class AuM

€790M

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

LU1646360971

TER

0.12%

Inception date

8/6/2003

Issuer

Amundi

Benchmark

MSCI EMU Index

Replication method

Dividend policy

Distributing

Compare similar ETFs

ETF Name	1w perf.
MFEC Amundi Core MSCI EMU UCITS ETF	+1.03%
ZPRE State Street SPDR MSCI EMU UCITS ETF	+1.03%
XD5E Xtrackers MSCI EMU UCITS ETF	+1.06%
EEAG BNP Paribas Easy MSCI EMU UCITS ETF	+0.89%
CSEMU iShares Core MSCI EMU UCITS ETF	+1.03%
EZU iShares MSCI Eurozone ETF	+0.76%
EMUAA UBS Core MSCI EMU UCITS ETF	+1.03%
HEZU iShares Currency Hedged MSCI Eurozone ETF	+1.23%
EMUU iShares MSCI EMU USD Hedged UCITS ETF (Acc)	+1.05%
EMUC iShares MSCI EMU CHF Hedged UCITS ETF	+0.99%
FLEU Franklin FTSE Eurozone ETF	+0.81%
EEMU BNP Paribas Easy MSCI EMU Min TE UCITS ETF	+1.04%
PRAZ Amundi Prime Eurozone UCITS ETF	+1.09%
VEZU Vanguard FTSE Eurozone UCITS ETF	+0.90%
DECD Amundi MSCI EMU Screened UCITS ETF	+0.98%

API

PerformanceDec 31, 2025 - Aug 12, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 06/30/26

Finance

26.50%

Industrials

19.38%

Technology

16.78%

Consumer Cyclicals

7.47%

Utilities

6.14%

Consumer Non-Cyclicals

5.84%

Non-Energy Materials

5.16%

Healthcare

4.72%

Unavailable

0.20%

Other

7.82%

Latest LYMFE news

No content available for this fund

FAQ about LYMFE

LYMFE is a Passive ETF. This ETF provides exposure to Large and Mid-Cap Eurozone Equities.

LYMFE tracks the MSCI EMU EUR Net Total Return Index - EUR, through a full replication replication method.

LYMFE carries a total expense ratio (TER) of 0.12%, indicating the annual cost for holding the fund.

LYMFE was introduced to the market on August 6, 2003. It trades on Japan, among other exchanges

Amundi Core MSCI EMU UCITS ETF, LYMFE, is provided by Amundi. Learn more about Amundi here.

Yes, LYMFE is available in multiple share classes, which may differ by distribution policy (e.g., accumulating vs. distributing), currency or hedging. Explore the different share classes .

LYMFE oversees €790M in assets as of August 12, 2026.

LYMFE follows a distributing dividend policy, meaning it pays out income to investors. As of August 12, 2026, its 12-month trailing yield was 2.82%.

As of June 30, 2026, LYMFE has significant geographic allocations in France, Germany and Netherlands.

As of June 30, 2026, LYMFE focuses largely on Finance, Industrials and Technology.

As of June 30, 2026, LYMFE holds 230 positions in its portfolio, with 37.67% of assets concentrated in its top 15 holdings.

As of June 30, 2026, LYMFE top three holdings include ASML Holding NV, Siemens AG and Banco Santander SA.

The base currency of LYMFE is EUR.

Top 10 holdings

Data as of 06/30/26

ASML Holding NV

9.10%

Siemens AG

3.04%

Banco Santander SA

2.56%

Allianz SE

2.32%

Schneider Electric SE

2.32%

SAP SE

2.12%

TotalEnergies SE

2.06%

Iberdrola SA

1.94%

Siemens Energy AG

1.87%

LVMH Moët Hennessy Louis Vuitton SE

1.85%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

The Ultimate ETF Comparison Tool - Try Now!

Amundi Core MSCI EMU UCITS ETF

FAQ about LYMFE

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US